Nigeria will continue its plans to test for malaria hydroxychloroquine for covid19 victims despite the World Health Organization warning to stop testing because of it’s side effects.
The head of the National Agency for Food and Drug Administration and Control (NAFDAC), Mojisola Adeyeye, said that she does not dispute the WHO’s position but wants the drug to be tested in the country so they can see the impact.
“I do not know what they want to achieve, whether they are studying Caucasians or Africans. If they want to achieve a goal and try the vaccine against the Caucasian community, there is no crime. But I don’t think they have had the effect of the treatment on the African people, because our genes are different from those, “she said.
Prof Adeyeye added that the trial would be completed within three to four months.
A study published in the scientific journal “The Lancet”, recently showed that the drug could lead to death for an infected cat.
